Stryker Hip Implants Multidistrict Litigation Settlement Announced

On November 2, 2018, Stryker and National Plaintiff’s Leadership in MDL 2768 of the consolidated proceedings before Judge Talwani announced in Court a proposed Master Settlement Agreement (MSA) for eligible claimants. The Stryker Hip Settlement includes those cases filed in the MDL 2768 in Massachusetts, the MCL 624 consolidated proceedings in New Jersey and/or other jurisdictions for cases already filed and pending. It is believed the eligibility of the failed implants include both recalled and unrecalled cobalt chromium V40 heads and compatible stem system configurations including Accolade TMZF, Accolade 2, Citation, Meridian and Rejuvenate.

The initial settlement terms are confidential and were not publicly disclosed. The settlements amounts are believed to vary and criteria for amounts of individual offers will be based upon varying factors including the degree of harm and components necessitated to be removed. It was stated that the settlement will not settle all filed claims. It is believed, however, to be a substantial step to begin resolving claims in the underlying Stryker hip litigation. It is believed that this settlement will resolve the first cases picked for the initial Bellwether trials and discovery will be stayed through the Summer of 2019.

If your business is presently or may soon be involved in multidistrict litigation (MDL) in the United States, email us at or telephone us toll-free in the United States at 800-756-2143 to find MDL lawyers who may handle your MDL litigation matter on a contingency basis. – The Practical Solution For Business Litigation